Literature DB >> 15847716

Gatifloxacin Therapy in Otitis Media in Children.

Itzhak Brook.   

Abstract

Entities:  

Year:  2005        PMID： 15847716     DOI： 10.1007/s11908-005-0028-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  9 in total

1.  Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-09-21       Impact factor: 17.586

Review 2.  Clinical significance of resistant organisms in otitis media.

Authors:  R Dagan
Journal:  Pediatr Infect Dis J       Date:  2000-04       Impact factor: 2.129

Review 3.  In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.

Authors:  R N Jones; M A Pfaller
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

Review 4.  Quinolone arthropathy in animals versus children.

Authors:  J E Burkhardt; J N Walterspiel; U B Schaad
Journal:  Clin Infect Dis       Date:  1997-11       Impact factor: 9.079

Review 5.  Recurrent and persistent otitis media.

Authors:  M E Pichichero
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

6.  Failure of antibiotic therapy in acute otitis media.

Authors:  Emmanuel Babin; Vincent Lemarchand; Sylvain Moreau; Marc Goullet de Rugy; André Valdazo; Arnaud Bequignon
Journal:  J Laryngol Otol       Date:  2003-03       Impact factor: 1.469

7.  The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?

Authors:  Lionel A Mandell; Lance R Peterson; Richard Wise; David Hooper; Donald E Low; Urs B Schaad; Keith P Klugman; Patrice Courvalin
Journal:  Clin Infect Dis       Date:  2002-08-20       Impact factor: 9.079

8.  Comparison of the in vitro activities of several new fluoroquinolones against respiratory pathogens and their abilities to select fluoroquinolone resistance.

Authors:  F J Boswell; J M Andrews; G Jevons; R Wise
Journal:  J Antimicrob Chemother       Date:  2002-10       Impact factor: 5.790

9.  Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults.

Authors:  Lionel A Mandell; John G Bartlett; Scott F Dowell; Thomas M File; Daniel M Musher; Cynthia Whitney
Journal:  Clin Infect Dis       Date:  2003-11-03       Impact factor: 9.079
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.